Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Rotavirus Vaccines
Rotavirus Vaccines
14 registered clinical trials studyying Rotavirus Vaccines.
Status
Trial
Sponsor
Phase
Completed
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
NCT06882070
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
—
Unknown
Using "Decision Aids" to Help the Infant Family to Decide the Use of Oral Rotavirus Vaccine
NCT03804489
Taipei Medical University Shuang Ho Hospital
N/A
Completed
Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Fr
NCT05037435
Limited Liability Company Pharm Aid
Phase 3
Completed
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix
NCT03207750
GlaxoSmithKline
Phase 3
Completed
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine
NCT02914184
GlaxoSmithKline
Phase 3
Completed
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroent
NCT01733862
GlaxoSmithKline
—
Completed
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
NCT00995813
Seattle Children's Hospital
Phase 4
Completed
Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants
NCT00969228
GlaxoSmithKline
Phase 4
Unknown
Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea
NCT00669929
Yonsei University
—
Completed
Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children
NCT01177826
GlaxoSmithKline
—
Completed
Intussusception Surveillance After Rotarix Introduction in Mexico
NCT00595205
GlaxoSmithKline
—
Completed
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants
NCT00480324
GlaxoSmithKline
Phase 3
Completed
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy
NCT00432380
GlaxoSmithKline
Phase 2
Completed
To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6
NCT00353366
GlaxoSmithKline
—